Does ALPRAZOLAM Cause Cardiovascular insufficiency? 11 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Cardiovascular insufficiency have been filed in association with ALPRAZOLAM (Alprazolam). This represents 0.0% of all adverse event reports for ALPRAZOLAM.
11
Reports of Cardiovascular insufficiency with ALPRAZOLAM
0.0%
of all ALPRAZOLAM reports
0
Deaths
10
Hospitalizations
How Dangerous Is Cardiovascular insufficiency From ALPRAZOLAM?
Of the 11 reports, 10 (90.9%) required hospitalization, and 7 (63.6%) were considered life-threatening.
Is Cardiovascular insufficiency Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALPRAZOLAM. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does ALPRAZOLAM Cause?
Drug abuse (8,827)
Toxicity to various agents (7,157)
Completed suicide (4,873)
Drug ineffective (4,040)
Overdose (2,967)
Drug dependence (2,743)
Somnolence (2,461)
Intentional overdose (2,389)
Death (2,317)
Suicide attempt (2,313)
What Other Drugs Cause Cardiovascular insufficiency?
FUROSEMIDE (51)
METFORMIN (47)
AMLODIPINE (41)
SACUBITRIL\VALSARTAN (38)
SODIUM (36)
DEXAMETHASONE (34)
BISOPROLOL (32)
FLUCONAZOLE (31)
METHYLPREDNISOLONE (30)
DEXTROSE (29)
Which ALPRAZOLAM Alternatives Have Lower Cardiovascular insufficiency Risk?
ALPRAZOLAM vs ALPROSTADIL
ALPRAZOLAM vs ALTEPLASE
ALPRAZOLAM vs ALTERNARIA ALTERNATA
ALPRAZOLAM vs ALTHIAZIDE
ALPRAZOLAM vs ALTHIAZIDE\SPIRONOLACTONE